155 related articles for article (PubMed ID: 38570378)
1. Changes in the Urinary Microbiome After Transurethral Resection of Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study.
Ślusarczyk A; Ismail H; Zapała Ł; Piecha T; Zapała P; Radziszewski P
Ann Surg Oncol; 2024 Jul; 31(7):4773-4786. PubMed ID: 38570378
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.
Elsawy AA; Harraz AM; Ghobrial FK; Abdullatef M; Ali-El-Dein B
Urol Oncol; 2020 Dec; 38(12):935.e1-935.e8. PubMed ID: 32654947
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Urobiome in Patients With Bladder Cancer and Implications for Clinical Outcome: A Single-Institution Study.
Zeng J; Zhang G; Chen C; Li K; Wen Y; Zhao J; Wu P
Front Cell Infect Microbiol; 2020; 10():555508. PubMed ID: 33384966
[TBL] [Abstract][Full Text] [Related]
4. Investigating the association between the urinary microbiome and bladder cancer: An exploratory study.
Hussein AA; Elsayed AS; Durrani M; Jing Z; Iqbal U; Gomez EC; Singh PK; Liu S; Smith G; Tang L; Guru KA
Urol Oncol; 2021 Jun; 39(6):370.e9-370.e19. PubMed ID: 33436328
[TBL] [Abstract][Full Text] [Related]
5. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
6. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K
Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327
[TBL] [Abstract][Full Text] [Related]
9. Implications of the COVID19 pandemic on the need and timing of second transurethral bladder tumour resection in high-grade non-muscle invasive bladder cancer.
Vanneste M; van der Heij B; Christiaansen CE; Berendsen CL; Driessen EJM; Bruins HM
World J Urol; 2023 Aug; 41(8):2173-2178. PubMed ID: 37328699
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Risk Factors for Recurrence after Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder Cancer: 2-Year Follow-Up Outcomes.
Li H; Wang L; Li H; Zhang P; Li Z; Xue L; Wang Z; Fu D; Chen Q; Luo Q; Chong T; Wang Z
Oncology; 2024; 102(4):337-342. PubMed ID: 37647883
[TBL] [Abstract][Full Text] [Related]
11. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
[TBL] [Abstract][Full Text] [Related]
12. Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.
Wu P; Zhang G; Zhao J; Chen J; Chen Y; Huang W; Zhong J; Zeng J
Front Cell Infect Microbiol; 2018; 8():167. PubMed ID: 29904624
[TBL] [Abstract][Full Text] [Related]
13. Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients.
Pederzoli F; Ferrarese R; Amato V; Locatelli I; Alchera E; Lucianò R; Nebuloni M; Briganti A; Gallina A; Colombo R; Necchi A; Clementi M; Montorsi F; Mancini N; Salonia A; Alfano M
Eur Urol Oncol; 2020 Dec; 3(6):784-788. PubMed ID: 32345542
[TBL] [Abstract][Full Text] [Related]
14. Pathology in repeated transurethral resection of a bladder tumor as a risk factor for prognosis of high-risk non-muscle-invasive bladder cancer.
Tae BS; Jeong CW; Kwak C; Kim HH; Moon KC; Ku JH
PLoS One; 2017; 12(12):e0189354. PubMed ID: 29244843
[TBL] [Abstract][Full Text] [Related]
15. Does the urinary microbiome profile change after treatment of bladder cancer?
Hussein AA; Bhat TA; Jing Z; Gomez EC; Wasay MA; Singh PK; Liu S; Smith G; Guru KA
World J Urol; 2023 Dec; 41(12):3593-3598. PubMed ID: 37796319
[TBL] [Abstract][Full Text] [Related]
16. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
[TBL] [Abstract][Full Text] [Related]
17. The Microbiome of Catheter Collected Urine in Males with Bladder Cancer According to Disease Stage.
Oresta B; Braga D; Lazzeri M; Frego N; Saita A; Faccani C; Fasulo V; Colombo P; Guazzoni G; Hurle R; Rescigno M
J Urol; 2021 Jan; 205(1):86-93. PubMed ID: 32856979
[TBL] [Abstract][Full Text] [Related]
18. Correlation between urine cytology results on the day after overnight continuous saline irrigation following transurethral resection of bladder tumor and bladder tumor recurrence.
Kim DH; Choi MS; Choi JH; Lee C; Jeh SU; Kam SC; Hwa JS; Hyun JS; Choi SM
Investig Clin Urol; 2024 May; 65(3):279-285. PubMed ID: 38714518
[TBL] [Abstract][Full Text] [Related]
19. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
[TBL] [Abstract][Full Text] [Related]
20. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
